Recent analysis of the pharmacological records reported an SMBG test rate of 3.99 tests/day and 2.61 tests/day, respectively, for Polish patients with T1DM and type 2 diabetes mellitus (T2DM) treated with insulin.9 Similar data can be observed in other European countries.10 Some of the likely reasons for measuring blood glucose levels less frequently than recommended are due to the invasiveness and the pain associated with finger pricks as well as the inconvenience and social embarrassment associated with testing.11 The gene discussed is INS; the disease is diabetes mellitus.